Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.
Glass is mysterious. It is a broad class of materials that extends well beyond the everyday window pane, but one thing that these disparate glasses seem to have in common is that they have nothing in common when it comes to their internal structures, especially in contrast with highly ordered and patterned crystals.
A new chemical-genetic therapy restores light responses to the retinas of blind mice and dogs and enables the mice to guide their behavior according to visual cues, setting the stage for clinical trial in humans.
By Madeleine Stone @themadstone
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk.
Arrests for violence committed by disadvantaged urban adolescents decrease by as much as 43 percent when the young people have summer jobs, according to new research from the University of Pennsylvania.
Origami is capable of turning a simple sheet of paper into a pretty paper crane, but the principles behind the paper-folding art can also be applied to making a microfluidic device for a blood test, or for storing a satellite's solar panel in a rocket’s cargo bay.
Mitesh Patel of the Perelman School of Medicine comments on boosting the frequency of physicians prescribing generic br